Celgene has supported a funding round for Oncorus, an immuno-oncology treatment developer exploiting research conducted at Pittsburgh.

Nokia Growth Partners joined existing backer Bauer Media to contribute to a series B round which will help the health tracking app developer expand in the US.

Oxford spinout Immago Biosystems, which is working on increasing the efficiency of antibody-based cancer therapies, has been acquired by Hansa Medical.

Johnson & Johnson invested $6m to help radiotherapy equipment developer Reflexion Medical close out its Pfizer-backed series B round at $52m.

Celgene has supported a funding round for Oncorus, an immuno-oncology treatment developer that is focusing on brain cancer.

Hovione Scientia and Consort Medical both contributed capital as Precision Cocular extended a series A round that will fund its pipeline of retinal disease treatments.

ABB has contributed to a series A round for Cambridge Medical Robotics, a startup working on robot-assisted keyhole surgery.

VIB-affiliated V-Bio Ventures has joined a series A round for the retinal treatment developer that already included Imperial Innovations.

Second Genome, which is applying genomics technology to the microbiome, is the latest in a growing string of gene technology companies to raise substantial funding.

Internet company Yandex was among the participants in a Baring Vostok-led round that will enable Russia-based Doc+ to expand across the country.